Balancing Act: Precision Medicine and National Security
Abstract
Developments in genetics, pharmacology, biomarker identification, imaging, and interventional biotechnology are enabling medicine to become increasingly more precise in “personalized” approaches to assessing and treating individual patients. Here we describe current scientific and technological developments in precision medicine and elucidate the dual-use risks of employing these tools and capabilities to exert disruptive influence upon human health, economics, social structure, military capabilities, and global dimensions of power. We advocate continued enterprise toward more completely addressing nuances in the ethical systems and approaches that can—and should—be implemented (and communicated) to more effectively inform policy to guide and govern the biosecurity and use of current and emerging bioscience and technology on the rapidly shifting global stage.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 30, 2021
- Source ID
- 10.1093/milmed/usab017
Entities
People
- Diane DiEuliis
- James Giordano
Organizations
- Georgetown University
- National Center for Advancing Translational Sciences
- National Defense University
- National Institutes of Health
- Naval War College